# Editor Review — Round 3

- **Manuscript:** "The prompt is the protocol: a disclosure standard for clinician-investigators using agentic large language models"
- **Manuscript version:** v0.4.1 (post-Round-2-minors)
- **Article type claimed:** Viewpoint, unsolicited
- **Reviewer role:** Deputy Editor (triage), *The Lancet Digital Health*
- **Date:** 2026-05-21
- **Model:** `claude-opus-4-7[1m]`
- **Round 1 verdict:** `revise-first-before-external-review` (13 comments)
- **Round 2 verdict:** `minor-revision` (4 operator-step items, 1 copy-edit), "would I send this out now? Yes"

---

## 1. Scope and triage verdict (first paragraph)

**Accept.** Round 2 closed at zero blocking issues at the manuscript level
with a clean "send out for external peer review" verdict; the four R2
operator-step items (medRxiv DOI, Zenodo DOI, four reviewer names, live
IFA re-verification) remain submission-day mechanics that no revision
pass can discharge in advance. Round 3 inspected the v0.4.1 commits
against the R2 minors crosswalk in `response-to-reviewers.md` and found
that every R2 minor flagged for in-document remediation has been applied
in the manuscript body: clinician N1 (Layer~N non-breaking hyphenation
in §4), clinician N2 (case-study journal selection now references
`case-study/manuscript/JOURNAL.md` rather than "of its own choice"),
clinician N3 (operator-in-the-loop role explicit in §4 paragraph 2),
methodology N3 (reviewer-AI collusion and selective-preservation-across-
uncommitted-runs added to Limitations), policy N1 (title-page word
count). One quantitative regression surfaced (body word count is now
2 428, not 2 281, because clinician N3 and methodology N3 each added
content); it is comfortably under the 2 500 ceiling and is a copy-edit-
level disclosure update, not a triage block. **Verdict: accept onto
external-review queue; minor-revision in house terminology; no further
manuscript-level edits required before clicking Submit beyond the four
operator-step items that R2 already named.**

---

## 2. Format compliance against JOURNAL.md and the live IFA

The live Lancet DH IFA URL set returned **HTTP 403 again on 2026-05-21**;
this is now the third consecutive round in which I cannot independently
verify the 2 500 / 30 / 2 ceilings against the live document, and the
operator's submission checklist in `manuscript/JOURNAL.md` correctly
flags this as an operator step.

| Item | Ceiling | R1 | R2 | R3 (v0.4.1) | Verdict |
|---|---|---|---|---|---|
| Body word count | <=2 500 | 2 173 | 2 281 | **2 428** (texcount body sections) | **Pass.** 72 words of headroom; up 147 words from R2 because clinician N3 (operator role in §4) added 72 words and methodology N3 (two new Limitations entries) added 75 words. |
| References | <=30 | 11 effective | 14 | **14** | **Pass.** 16 headroom. |
| Display items | <=2 | 2 | 2 | 2 | **Pass.** |
| Title length | <=150 chars | 122 | 122 | 122 | **Pass.** |
| Running title | <=50 chars | 45 | 45 | 45 | **Pass.** |
| Key messages | <=5 bullets | 4 misordered | 4 contribution-first | 4 unchanged | **Pass.** |
| Citation style | Vancouver superscript-numeric | unchanged | unchanged | unchanged | **Pass (operator-attested).** |
| Search-strategy panel | required | present | "AI use" subsection added | unchanged | **Pass.** |
| Five declarations | required | four present | all five | unchanged | **Pass.** |
| AI disclosure | Methods-equiv + Ack | Ack only | both, "no AI author" | unchanged | **Pass.** |
| ORCID | required | present | unchanged | unchanged | **Pass.** |
| Postal address | required | absent | present | unchanged (line 63) | **Pass.** |
| Body placeholders | none | three | none | none | **Pass.** |
| Reporting guideline | TRIPOD+STROBE | absent | declared §4 last ¶ | unchanged | **Pass.** |
| Figures | no AI, vector PDF >=300 dpi | declared | unchanged | unchanged | **Pass.** |
| Layer~N hyphenation | non-breaking in §4 | mixed | flagged as N1 | **resolved** (Layer~1, Layer~2, Layer~3 throughout §4) | **Pass.** |
| Operator role disclosure | explicit | implicit | flagged as N3 | **explicit** (§4 ¶2: "(i) supplying the domain prompt..., (ii) approving each commit and tag..., (iii) executing the Layer~3...; the operator did not edit Layer 1 outputs, did not modify reviewer-subagent comments, and did not select Layer 3 cohorts based on Layer 1's result") | **Pass.** |
| Case-study journal selection wording | named, not "of its own choice" | flagged as N2 | **resolved** ("targeting a clinical-genomics journal of its own selection (recorded in `case-study/manuscript/JOURNAL.md`)") | **Pass.** |

### 2.1 The word-count discrepancy that R2 flagged is regenerated

R2's editor.md flagged that title-page metadata reported 2 310 while
cover letter reported 2 281; the v0.4.1 fix per policy N1 was to align
both at 2 281. In the same revision pass, clinician N3 and methodology
N3 each prompted content additions in §4 and §7 respectively:

- **§4 (Case study)** in R2: 383 words. In v0.4.1: **455 words** (+72).
  The added content is the operator-in-the-loop tripartite list and the
  three corresponding operator-NOT clauses. Both are content-bearing and
  responsive to clinician N3; cutting them would re-open the R2 minor.

- **§7 (Limitations)** in R2: 158 words. In v0.4.1: **233 words** (+75).
  The added content is the reviewer-AI-collusion paragraph fragment and
  the selective-preservation-across-uncommitted-runs fragment. Both are
  responsive to methodology N3.

Sum of body sections (per texcount on 2026-05-21):
282+290+343+**455**+505+241+**233**+79 = **2 428** body words. The
title-page metadata (line 60) still reads "2 281", and the cover letter
(line 58) still reads "2 281". Both numbers are now stale by 147 words
relative to the current section sums.

**Triage decision on the discrepancy.** The actual count (2 428) is
still 72 words under the 2 500 ceiling, so the format envelope holds.
The internal disagreement between title page (2 281) and section sums
(2 428) is a copy-edit-level error of the same class as the R2 minor
the operator just fixed; it is not a triage block but it is the kind of
detail a Lancet copy-editor will catch and return. **Recommended R3
operator step: update title-page metadata (`main.tex` line 60) and
cover-letter metadata table (`cover-letter.md` line 58) to 2 428 to
match texcount.** Treat this as the single R3 minor; it does not delay
sending the manuscript out for external peer review.

### 2.2 What did not change

- References: 14 (`grep -c "^@" references.bib` = 14, all four numbers
  in title page / cover letter / response document agree).
- Figures: `figures/build_fig1.py`, `figures/build_fig2.py`,
  `figures/fig1-artifact-ledger.pdf`, `figures/fig2-policy-gap.pdf` all
  present (existence-verified, not pixel-audited).
- Key Messages order, Search-strategy panel content, Acknowledgements
  paragraph, Data sharing block: unchanged from R2.

### 2.3 Live IFA verification — still operator step

Third consecutive round of HTTP 403 on all three IFA URLs. The
2 500/30/2 ceiling has been operator-asserted across three rounds and
remains uncorroborated by the live document. The submission checklist
in `manuscript/JOURNAL.md` flags this; if the live PDF on submission
day shows 1 500/20 (the *Lancet* main-title Viewpoint format), the
manuscript needs a 40% cut and a fresh revision pass. This risk has not
been retired, and cannot be retired without institutional access to the
PDF.

---

## 3. Round 2 minor-by-minor verification

The R2 minors named in `reviewer-logs/viewpoint-round-02/response-to-
reviewers.md` table:

| # | Reviewer | Minor | Status in v0.4.1 | Evidence |
|---|----------|-------|------------------|----------|
| 1 | policy N1 | word-count discrepancy main.tex 2310 vs cover-letter 2281 | **✓ resolved at v0.4.1 time, ✗ regenerated** | Title page now reads "2\,281" (line 60); cover letter reads "2 281" (line 58). Both agree with each other but disagree with current texcount (2 428). See §2.1 above. The v0.4.1 fix was correctly applied; the disagreement was reintroduced by the simultaneous clinician-N3 and methodology-N3 content additions in the same revision pass. **New R3 copy-edit: bring both numbers to 2 428.** |
| 2 | policy N2 | `lintom2026`, `linehs2024` verification notes at submission | ◐ operator-step | Both bib entries retain the "to be verified at submission" notes; the response-to-reviewers correctly defers these. Acceptable. |
| 3 | policy N3 | JOURNAL.md interpretive sentence bleed into EM metadata | ◐ operator-step | `JOURNAL.md` is the operator's working spec; EM submission metadata is the cover-letter table. Both remain distinct. Acceptable. |
| 4 | clinician N1 | Layer~N vs Layer N hyphenation in §4 | **✓** | Section 4 (lines 87, 133, 135) uses non-breaking hyphen `Layer~1`, `Layer~2`, `Layer~3` throughout. Two non-tilde occurrences survive in §4 paragraph 2 ("did not edit Layer 1 outputs", "did not select Layer 3 cohorts") and one in Figure 1 caption (line 140: "Layer 1 Pipeline, Layer 2 Audit, Layer 3 External Validation"). The non-tilde forms in paragraph 2 are stylistically defensible (they refer to the layer as an entity rather than the labelled checkpoint, and TeX hyphenation in mid-sentence prose is conventional); the figure caption is a proper-name-style usage of "Layer 1 Pipeline" / "Layer 2 Audit" / "Layer 3 External Validation" and is correct as written. The clinician's R2 N1 critique was about the labelled-checkpoint usages, which are now uniformly non-breaking. **Resolved.** |
| 5 | clinician N2 | §4 should name the journal Layer 1 selected | **✓** | Line 133: "a draft manuscript targeting a clinical-genomics journal of its own selection (recorded in `case-study/manuscript/JOURNAL.md`)". This is the lower-disruption fix that names the recorder rather than the journal itself; it permits the case-study Layer-1 journal selection to remain as it currently stands without binding the Viewpoint to that choice. Editorially correct. |
| 6 | clinician N3 | §4 under-claims operator role | **✓** | Line 133, second sentence onward: "The operator's in-the-loop role across the pipeline is restricted to (i) supplying the domain prompt and the orchestration prompts (committed verbatim, closed for edits), (ii) approving each commit and tag before push, and (iii) executing the Layer~3 external validation; the operator did not edit Layer 1 outputs, did not modify reviewer-subagent comments, and did not select Layer 3 cohorts based on Layer 1's result." The tripartite list of operator tasks and the matching tripartite list of operator-NOT tasks is exactly the disclosure the clinician reviewer asked for, and it is the editorially most useful single sentence in §4. **Strong resolution.** |
| 7 | methodology N1 | schema does not couple toolEnvelope keys to models[].name | **✓** | `docs/disclosure2-schema.json` toolEnvelope.description now documents the coupling rule. Not visible in the Viewpoint manuscript body but is the artefact the manuscript points at; existence-verified on disk. |
| 8 | methodology N2 | `docs/ledger.md` lags HEAD by 2 commits | ◐ operator-step | Will regenerate at every commit going forward; release_check.sh enforces. Acceptable as an operator commitment. |
| 9 | methodology N3 | reviewer-AI collusion and selective-preservation failure modes absent from Limitations | **✓** | Line 178: "Two further residual blind spots the manifest does not catch: \emph{reviewer-AI collusion} (nothing prevents an operator from running Layer~1 and reviewer subagents from the same model with subtly biasing persona-prompt edits; the personas are committed but the invocation is not auditable) and \emph{selective preservation across uncommitted runs} (an operator who ran Layer~1 three times and only committed the third would not technically violate the no-history-rewriting rule if the earlier runs were never committed)." Both new failure modes named, both with concrete operationalisation; this is exactly the methodology reviewer's requested addition. The 75-word growth of §7 is the cost; the disclosure value is worth it. **Strong resolution.** |
| 10 | editor N1 (R2) | title-page word-count internal disagreement | **✓ at v0.4.1, ✗ regenerated by simultaneous content additions** | See policy N1 above. The R2 fix to 2 281 was applied; clinician N3 + methodology N3 then added 147 words without the title-page count being re-updated. New R3 copy-edit. |
| 11 | editor N2 (R2) | April 2026 LDH editorial citation | ✗ operator-step | Live LDH site continues to return HTTP 403; the editorial's existence remains surfaced by WebSearch snippet only. Section 1 paragraph 1 cites Zou & Topol 2025 as the verified analogue and folds the April 2026 LDH piece into "Both deployment-side editorials defer the manuscript-preparation question". Acceptable; the operator's submission-day re-search is the closing step. |
| 12 | editor N3 (R2) | Acknowledgements paragraph density | ◐ deferred | The 181-word Acknowledgements remains a dense single paragraph carrying the mandated content. Breaking it into two paragraphs is a Lancet copy-edit-pass concern, not an editor triage concern. Acceptable. |

**Aggregate R2-minor resolution score.** Of the 12 R2 minors, 6 are
fully resolved in v0.4.1 (clinician N1, N2, N3; methodology N1, N3;
policy N1 at the moment of fix), 5 are correctly carried forward as
operator-step deferrals (policy N2, N3; methodology N2; editor N2,
N3), and 1 is regenerated by the same revision pass that fixed it
(policy N1 / editor N1 — the title-page word count is again stale,
this time relative to 2 428). **Zero blocking issues survive at the
manuscript level. One copy-edit-level R3 minor flagged.**

---

## 4. New issues surfaced by v0.4.1 (one copy-edit, none blocking)

1. **Title-page word-count internal disagreement, regenerated.** Title
   page (line 60) and cover letter (line 58) both report 2 281; current
   texcount of body sections returns 2 428 (a +147-word change driven
   by clinician N3 and methodology N3 content additions in the same
   revision pass). The actual figure is still 72 words under the 2 500
   ceiling, so the format envelope holds; the internal disagreement is
   a copy-edit, not a triage block. **Single R3 operator action: bump
   both metadata fields to 2 428 to match texcount.** This is the same
   class of fix the operator already applied at policy N1; the
   discipline is to refresh the count at every content commit.

2. **R3 reviewer-log forward references.** The Viewpoint body (line
   191, Search-strategy panel) references `reviewer-logs/viewpoint-
   round-01/` only. The R2 round's transcripts at
   `reviewer-logs/viewpoint-round-02/` are not cross-linked from the
   manuscript body. This is a minor disclosure point: the manuscript's
   "AI use in this Viewpoint" subsection promises that the reviewer-
   subagent transcripts are at `reviewer-logs/viewpoint-round-NN/`
   without committing to a specific NN. If the operator wants to
   strengthen the self-demonstration argument, a single line in the
   "AI use" subsection (line 191) listing all rounds (`viewpoint-round-
   01/` through `viewpoint-round-NN/` for the as-yet-unknown final NN)
   would close the loop. Pure suggestion; not a triage block.

3. **`reviewer-logs/round-NN/` (case-study)** still appears as a
   variable-NN reference in the Search-strategy panel (line 191). The
   case study has its own R1 transcripts elsewhere in the repo; the
   manuscript pointer is correct but unsharpened. Acceptable.

These three items together do not change the R3 verdict; the manuscript
is ready to send out for external peer review.

---

## 5. Cover-letter quality (R3 re-read)

Re-read of `cover-letter.md` v0.4.1:

1. **Word/ref/display counts:** 2 281 / 14 / 2. Reference and display
   counts match the manuscript and `references.bib`. Word count is
   stale by 147 words (see §4 item 1 above); the single R3 copy-edit is
   to bump to 2 428.
2. **`<<INSERT...>>` placeholders:** date, medRxiv DOI, Zenodo DOI,
   four reviewer slots. Same four operator-step items as R2; no change.
3. **Originality / exclusivity / COI / Funding / Generative-AI use
   paragraphs:** unchanged from R2; all read correctly.
4. **Generative-AI background of the author paragraph:** unchanged from
   R2; reads correctly ("My day job is as a haematology and medical
   oncology fellow; I am not an LLM researcher").
5. **Positioning sentence:** unchanged from R2; defensible on re-read.

**Cover-letter triage verdict:** ready to submit once the four
operator-step items are filled and the word-count metadata is bumped to
2 428.

---

## 6. Novelty vs the Lancet DH back catalogue (R3 update)

No change from R2. Section 1 ¶1 cites Zou & Topol (`zouAgentic2025`)
and the Nature 2026 editorial (`natureEditorial2026`) and asserts both
deployment-side editorials defer the manuscript-preparation question
the Viewpoint addresses. The April 2026 LDH "agentic AI colleague"
editorial remains an operator-step DOI confirmation; live LDH site
returned 403 again on 2026-05-21. Self-demonstration ("this Viewpoint
and its supporting case study are themselves produced under Disclosure
2.0") is in Key Messages bullet 3 and is the manuscript's strongest
asset.

---

## 7. Acceptance criterion per persona prompt

The persona prompt sets acceptance at: scope unambiguous, format
compliance total, novelty articulated against the journal's back
catalogue, and the manuscript would be sent out for external peer
review without further edits.

| Criterion | Status |
|---|---|
| Scope unambiguous | **Met.** Policy Viewpoint with concrete recommendations to the journal. |
| Format compliance total | **Met conditionally.** All operator-resolvable items resolved; live-IFA ceiling re-verification remains operator step for third consecutive round; one R3 copy-edit (word-count metadata refresh to 2 428) flagged. |
| Novelty articulated | **Met.** §1 positions explicitly against Zou & Topol and the Nature 2026 editorial; self-demonstration is novel against the LDH back catalogue. |
| Send out without further edits | **Met.** The one R3 copy-edit is a metadata refresh, not a content edit. It can be applied at the same submission-day pass that fills the four `<<INSERT...>>` placeholders. |

**Verdict: send this manuscript out for external peer review.** No
further revision pass is warranted; the operator's submission-day
checklist closes all remaining items.

---

## 8. What changes between Round 2 and Round 3

| Domain | R2 | R3 (v0.4.1) |
|---|---|---|
| Triage verdict | minor-revision, "would I send this out now? Yes" | **accept** (minor-revision in house terminology) |
| Blocking issues at manuscript level | 0 | **0** |
| Manuscript-level minors flagged | 1 (title-page word-count to 2281) | **1** (title-page word-count to 2428; regenerated by content additions) |
| Operator-step items | 4 | **4** (unchanged: medRxiv DOI, Zenodo DOI, reviewer names, IFA verification) |
| Body word count | 2 281 | **2 428** (within ceiling; +147 from clinician N3 + methodology N3) |
| References | 14 | 14 |
| §4 Case study | 383 words, operator role implicit | 455 words, **operator-in-the-loop tripartite list explicit** |
| §7 Limitations | 158 words, two failure modes absent | 233 words, **reviewer-AI collusion + selective-preservation explicit** |
| Layer~N hyphenation in §4 | mixed | **non-breaking on labelled-checkpoint usages** |
| Case-study journal wording | "of its own choice" | **"of its own selection (recorded in `case-study/manuscript/JOURNAL.md`)"** |
| `docs/disclosure2-schema.json` coupling rule | implicit | **explicit** |

The R2-minor revision pass landed cleanly. The single regenerated issue
(title-page word count is now stale by 147 words) is a discipline-of-
revision issue rather than a content issue and is addressable in the
same submission-day pass that fills the four `<<INSERT...>>` items.

---

## 9. Final triage decision

**Accept onto external-review queue.** Verdict: **minor-revision** in
house terminology; "accept" in plain language. Manuscript-level blocking
issues: zero. R3 copy-edit minors: one (refresh title-page and
cover-letter word count from 2 281 to 2 428). Operator-step items at
submission: four (unchanged from R2: medRxiv DOI, Zenodo DOI, four
reviewer names, live IFA re-verification), plus the April 2026 LDH
editorial DOI confirmation, plus branch protection on `main` at the
release tag.

The user-spec for the project requires at least four reviewer rounds;
Round 4 will be a confirmation round verifying the word-count metadata
refresh and any further submission-day fixes. The manuscript would not
benefit from a fifth content-revision pass at this point.

---

## Sources consulted (Round 3)

- `manuscript/main.tex` (v0.4.1, 215 lines, **2 428 body words** by texcount on 2026-05-21, 14 refs, 2 displays)
- `manuscript/JOURNAL.md`, `manuscript/cover-letter.md`, `manuscript/references.bib`
- `prompts/04-viewpoint-reviewer-editor.md`
- `reviewer-logs/viewpoint-round-01/editor.md` (R1, 13 comments)
- `reviewer-logs/viewpoint-round-02/editor.md` (R2, "would I send this out now? Yes")
- `reviewer-logs/viewpoint-round-02/response-to-reviewers.md` (R2 minors crosswalk)
- Live *Lancet Digital Health* IFA: **HTTP 403 again on 2026-05-21** (third consecutive round); ceiling re-verification remains operator step.
- `texcount -inc -sum manuscript/main.tex` on 2026-05-21: full sum 3 334; body sections 2 428 (282+290+343+455+505+241+233+79); headers 68; captions 110.
- `grep -c "^@" references.bib` returned 14.
- §4 hyphenation check: `Layer~1`, `Layer~2`, `Layer~3` non-breaking forms verified at lines 87, 133, 135, 144, 150, 152, 162, 174, 178; non-tilde "Layer 1 outputs", "Layer 3 cohorts" in line 133 are intentional prose-context usages.

---

## Structured decision

```json
{
  "reviewer": "editor",
  "round": 3,
  "verdict": "accept",
  "recommendation": "send-out-for-external-peer-review",
  "confidence": 0.9,
  "blocking_issues_at_manuscript_level": [],
  "r3_copy_edit_minors": [
    "Refresh title-page word count (main.tex line 60) from 2281 to 2428 to match texcount post-clinician-N3 + methodology-N3 content additions",
    "Refresh cover-letter metadata table (cover-letter.md line 58) from 2281 to 2428 to match"
  ],
  "operator_step_items_for_submission_day": [
    "Fill cover-letter date, medRxiv DOI, Zenodo DOI, four reviewer names",
    "Re-verify live Lancet DH IFA ceiling (third consecutive 403 from research IPs)",
    "Confirm or remove the April 2026 Lancet DH editorial citation after operator-level re-search",
    "Branch-protection on main at viewpoint-v1.0.0 tag"
  ],
  "r2_minors_resolved": 6,
  "r2_minors_operator_step": 5,
  "r2_minors_regenerated": 1,
  "r2_minors_outstanding": 0,
  "format_compliance": {
    "body_word_count_texcount": 2428,
    "body_word_count_reported_on_title_page": 2281,
    "body_word_count_reported_in_cover_letter": 2281,
    "body_word_count_ceiling": 2500,
    "headroom_words": 72,
    "reference_count": 14,
    "reference_count_ceiling": 30,
    "display_items": 2,
    "title_chars": 122,
    "running_title_chars": 45,
    "key_messages_bullets": 4,
    "key_messages_contribution_first": true,
    "search_strategy_panel_present": true,
    "ai_disclosure_acknowledgements_present": true,
    "ai_disclosure_methods_equivalent_present": true,
    "no_ai_author_statement_present": true,
    "limitations_encountered_statement_present": true,
    "reviewer_ai_collusion_documented": true,
    "selective_preservation_documented": true,
    "operator_in_loop_role_explicit_in_section_4": true,
    "case_study_journal_recorded_reference_present": true,
    "layer_n_nonbreaking_hyphen_in_section_4": true,
    "declarations_present": ["contributors", "competing_interests", "data_sharing", "acknowledgements", "role_of_funding_source"],
    "declarations_missing": [],
    "placeholders_unresolved_in_body": [],
    "placeholders_unresolved_in_cover_letter": ["INSERT_date", "INSERT_medRxiv_DOI", "INSERT_Zenodo_DOI", "INSERT_reviewer_1..4"]
  },
  "live_ifa_verification": {
    "attempted_2026_05_21": true,
    "result": "HTTP_403_on_all_three_urls_third_consecutive_round",
    "ceiling_re_verification_remains_operator_step": true
  },
  "regression_from_round_2": false,
  "would_send_out_for_external_review": true
}
```
